Electra Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -3.18%
- Market cap
- $574.60M
- 62.87M shares
- Filings
- 41
Q3 2026
—Q3 2026
—Q3 2026
——
—
—Q3 2026
—Q3 2026
—- $574.60M
- —
- —
- 1.5×
- —
- —
FY2026 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
No annual history for this metric yet.
| Period | Ended | Value | Kind | Source trail |
|---|
Biological products, except diagnostic substances
Electra Therapeutics, Inc. is the 61st largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
DNAGinkgo Bioworks Holdings, Inc.$170.2M25.1%183.8%$658.8MCADLCandel Therapeutics, Inc.———$658.2MGRMLGreenland Mines Ltd———$612.4MSRZNSurrozen, Inc.$3.5M67.4%6,960.8%$605.8MSANASana Biotechnology, Inc.———$599.3M
ETRAElectra Therapeutics, Inc. (this company)———$574.6M
ENTXEntera Bio Ltd.$42.0K76.8%27,235.7%$559.9MRGNXRegenxbio Inc.$170.4M104.5%113.8%$531.0MVALNValneva SE———$499.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Electra Therapeutics, Inc. · CIK 2088082 · Engraved from SEC EDGAR